Related references
Note: Only part of the references are listed.New perspectives on ferroptosis and its role in hepatocellular carcinoma
Tianhao Cong et al.
CHINESE MEDICAL JOURNAL (2022)
Current status, trends, and predictions in the burden of gallbladder and biliary tract cancer in China from 1990 to 2019
Shimin Chen et al.
CHINESE MEDICAL JOURNAL (2022)
Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer
Jian-Shu Lou et al.
PHYTOMEDICINE (2021)
Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
Pranavi Koppula et al.
PROTEIN & CELL (2021)
Cellular degradation systems in ferroptosis
Xin Chen et al.
CELL DEATH AND DIFFERENTIATION (2021)
Perspectives on the Role of Isoliquiritigenin in Cancer
Kai-Lee Wang et al.
CANCERS (2021)
SIRT3 inhibits gallbladder cancer by induction of AKT-dependent ferroptosis and blockade of epithelial-mesenchymal transition
Liguo Liu et al.
CANCER LETTERS (2021)
Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer
Yijian Zhang et al.
JOURNAL OF HEPATOLOGY (2021)
Modified FOLFIRINOX for unresectable locally advanced or metastatic gallbladder cancer, a comparison with GEMOX regimen
Xu-Ya Cui et al.
HEPATOBILIARY SURGERY AND NUTRITION (2021)
Ferroptosis is a type of autophagy-dependent cell death
Borong Zhou et al.
SEMINARS IN CANCER BIOLOGY (2020)
Current standards and future perspectives in adjuvant treatment for biliary tract cancers
Angela Lamarca et al.
CANCER TREATMENT REVIEWS (2020)
SIRT3 deficiency is resistant to autophagy-dependent ferroptosis by inhibiting the AMPK/mTOR pathway and promoting GPX4 levels
Dandan Han et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Dietary Compound Isoliquiritigenin, an Antioxidant from Licorice, Suppresses Triple-Negative Breast Tumor Growth via Apoptotic Death Program Activation in Cell and Xenograft Animal Models
Po-Han Lin et al.
ANTIOXIDANTS (2020)
Overview of current targeted therapy in gallbladder cancer
Xiaoling Song et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress
Xuemei Gu et al.
PHYTOMEDICINE (2020)
The Chemistry and Biology of Ferroptosis
Brent R. Stockwell et al.
CELL CHEMICAL BIOLOGY (2020)
Ascorbate and ferritin interactions: Consequences for iron release in vitro and in vivo and implications for inflammation
Charles Badu-Boateng et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Targeting Ferroptosis to Iron Out Cancer
Behrouz Hassannia et al.
CANCER CELL (2019)
Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis
Fabio Conforti et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Isoliquiritigenin Inhibits Ovarian Cancer Metastasis by Reversing Epithelial-to-Mesenchymal Transition
Chen Chen et al.
MOLECULES (2019)
Isoliquiritigenin (ISL) and its Formulations: Potential Antitumor Agents
Ting-Ting Zhao et al.
CURRENT MEDICINAL CHEMISTRY (2019)
A Dual Role of Heme Oxygenase-1 in Cancer Cells
Shih-Kai Chiang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Systemic therapy of gallbladder cancer: review of first line, maintenance, neoadjuvant and second line therapy specific to gallbladder cancer
Alexander A. Azizi et al.
CHINESE CLINICAL ONCOLOGY (2019)
Nrf2-Keap1 signaling in oxidative and reductive stress
Ilaria Bellezza et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2018)
Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis
Ling-Chu Chang et al.
CANCER LETTERS (2018)
Isoliquiritigenin suppresses human melanoma growth by targeting miR-301b/LRIG1 signaling
Shijian Xiang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Isoliquiritigenin-mediated p62/SQSTM1 induction regulates apoptotic potential through attenuation of caspase-8 activation in colorectal cancer cells
Hao Jin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2′, 4′-Tetrahydroxychalcone
Changliang Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Phytochemical and Pharmacological Role of Liquiritigenin and Isoliquiritigenin From Radix Glycyrrhizae in Human Health and Disease Models
Mahesh Ramalingam et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Dioscin Induces Gallbladder Cancer Apoptosis by Inhibiting ROS-Mediated PI3K/AKT Signalling
Xiaoling Song et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)
Isoliquiritigenin alleviates early brain injury after experimental intracerebral hemorrhage via suppressing ROS- and/or NF-κB-mediated NLRP3 inflammasome activation by promoting Nrf2 antioxidant pathway
Jun Zeng et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells
Xiaofang Sun et al.
HEPATOLOGY (2016)
DHX33 Transcriptionally Controls Genes Involved in the Cell Cycle
Baolei Yuan et al.
MOLECULAR AND CELLULAR BIOLOGY (2016)
Ferrootosis: Death by Lipid Peroxidation
Wan Seok Yang et al.
TRENDS IN CELL BIOLOGY (2016)
The Flavonoid Isoliquiritigenin Reduces Lung Inflammation and Mouse Morbidity during Influenza Virus Infection
Hussein Traboulsi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway
Maolan Li et al.
NATURE GENETICS (2014)
Icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS/JNK-dependent mitochondrial pathway
Songgang Li et al.
CANCER LETTERS (2010)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)
Share Paper
